Prescribing pattern of angiotensin-converting enzyme inhibitors and beta blockers after acute myocardial infarction

被引:0
|
作者
Sweileh, WM [1 ]
Shkokani, FM [1 ]
Sawalha, AF [1 ]
Al-Ramahi, RJ [1 ]
Jaradat, NA [1 ]
Zaid, AAM [1 ]
Barakat, AS [1 ]
机构
[1] An Najah Univ, Coll Pharm, Clin Pharm Grad Program, Palestine, Israel
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1837 / 1839
页数:3
相关论文
共 50 条
  • [41] Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors in Acute Myocardial Infarction Without Heart Failure
    Kim, Jihoon
    Kang, Danbee
    Park, Hyejeong
    Park, Taek Kyu
    Lee, Joo Myung
    Yang, Jeong Hoon
    Song, Young Bin
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Guallar, Eliseo
    Cho, Juhee
    Hahn, Joo-Yong
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (11):
  • [42] ASS, beta blocker and angiotensin-converting enzyme inhibitors as an initial therapy for acute myocardial infarction:: results from the Berlin myocardial infarction registry
    Hoffmann, S
    Mohadjer, A
    Maier, B
    Röhnisch, M
    Kuckuck, A
    EUROPEAN HEART JOURNAL, 2002, 23 : 726 - 726
  • [43] Angiotensin-Converting Enzyme Inhibitors and or Receptor Blockers After Acute Kidney Injury: Rehabilitation of the Supervillains
    Legrand, Matthieu
    Liu, Kathleen
    CRITICAL CARE MEDICINE, 2020, 48 (12) : 1922 - 1923
  • [44] Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction
    Di Pasquale, P
    Cannizzaro, S
    Scalzo, S
    Parrinello, G
    Fasullo, S
    Giambanco, F
    Fatta, A
    Paterna, S
    AMERICAN HEART JOURNAL, 2005, 150 (05) : 919.e1 - 919.e8
  • [45] Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction
    Krumholz, HM
    Chen, YT
    Wang, YF
    Radford, M
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (04) : 538 - 544
  • [46] Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction
    Ahmad, Monir
    White, Roselyn
    Tan, Junhui
    Huang, Bing S.
    Leenen, Frans H. H.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 51 (06) : 565 - 572
  • [47] Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation
    Wachtell K.
    Devereux R.B.
    Lyle P.A.
    Current Cardiology Reports, 2006, 8 (5) : 356 - 364
  • [48] Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction
    Fang, Gang
    Annis, Izabela E.
    Farley, Joel F.
    Mahendraratnam, Nirosha
    Hickson, Ryan P.
    Stuermer, Til
    Robinson, Jennifer G.
    PHARMACOTHERAPY, 2018, 38 (01): : 29 - 41
  • [49] Use of beta blockers, lipid lowering agents, and angiotensin converting enzyme-inhibitors before recurrent acute myocardial infarction
    Olomu, A. B.
    Dhoble, A.
    Siddiqi, A.
    Burton, K.
    Oluwole, D.
    Holmes-Rovner, M. M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 433 - 433
  • [50] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Acute Kidney Injury: Friend, Foe, or Acquaintance?
    Coca, Steven G.
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (04) : 263 - 265